[ad_1]
NEW DELHI: India is considering reviewing Pfizer Inc and AstraZeneca’s vaccines for emergency use on an accelerated foundation, a senior authorities official mentioned on Monday. Serum Institute is making AstraZeneca’s Covid-19 vaccine in India and has utilized for emergency use authorization.
Pfizer utilized for emergency use authorization of its coronavirus vaccine over the weekend, the official mentioned.
“We are in the process of reviewing. It is an accelerated reviewing process, which is there for Serum too,” the federal government official mentioned. “All applications are accelerated. It is the need of the hour.”
(This story has not been edited by Newslivenation workers and is auto-generated from a syndicated feed.)
PreetiJha